Quillivant XR FDA Approval History
FDA Approved: Yes (First approved September 27, 2012)
Brand name: Quillivant XR
Generic name: methylphenidate
Dosage form: for Extended-Release Oral Suspension
Company: NextWave Pharmaceuticals, Inc.
Treatment for: ADHD
Quillivant XR (methylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Development timeline for Quillivant XR
| Date | Article |
|---|---|
| Oct 1, 2012 | Approval NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR for Once-Daily Treatment of ADHD |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
